<DOC>
	<DOCNO>NCT02610283</DOCNO>
	<brief_summary>This trial design evaluate QPI-1002 versus placebo prevention AKI subject high risk AKI follow cardiac surgery . Half participant receive QPI-1002 half receive placebo .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety QPI-1002 Prevention Acute Kidney Injury Following Cardiac Surgery</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , Phase 2 trial evaluate QPI-1002 versus placebo prevention AKI subject high risk AKI follow cardiac surgery .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>Have ability understand requirement study , able provide write informed consent willing able comply requirement study Male female , age ≥ 45 year old . Have stable renal function per Investigator assessment know increase serum creatinine ≥ 0.3 mg/dL precede 4 week . Scheduled undergo nonemergent open chest cavity cardiovascular surgery , include use coronary pulmonary bypass ( CPB ) CPB : Combined coronary artery bypass grafting ( CABG ) surgery surgery one cardiac valve ( valve ( ) surgery ) least 1 AKI Risk Factor ; Surgery one cardiac valve ( valve surgery ) least 1 AKI Risk Factor ; Surgery aortic root ascend part aorta , combination aortic valve , least 1 AKI Risk Factor ; circulatory arrest exclude ; Aortic root ascend part aorta , combine CABG and/or valve ( ) surgery least 1 AKI Risk Factor ; circulatory arrest exclude ; If CABG single valve surgery , subject require least 2 AKI Risk Factors : AKI Risk Factors : Age ≥ 70 year eGFR ≤ 60 ml/min/1.73m2 CKDEPI formula Screening . Diabetes ( Type 1 2 ) , require least 1 oral hypoglycemic agent insulin Proteinuria ≥ 0.3g/d , spot UPCR ≥ 0.3g/gm urine dip stick ≥ +2 History congestive heart failure require hospitalization Have eGFR ≤ 20 mL/min/1.73 m2 Subjects eGFR ≤ 60 mL/min/1.73 m2 require intravascular iodinate contrast within 48 hour day surgery . However , subject may include post contrast increase serum creatinine &lt; 0.3 mg/dl least 2 serum creatinine evaluation perform less 36 hour apart . Have history organ cellular transplant require active immunosuppressive treatment interfere kidney function Emergent surgery , include aortic dissection , major congenital heart defect Scheduled undergo transcatheter aortic valve implantation ( TAVI ) transcatheter aortic valve replacement ( TAVR ) single vessel , midCAB offpump surgery leave ventricular assist device ( LVAD ) implantation Have participate investigational drug study last 30 day Have know allergy participate prior study siRNA Have history human immunodeficiency virus ( HIV ) infection Have know active Hepatitis B ( HBV ) ( Note : Subjects serological profile suggestive clearance , prior antiviral treatment HBV infection may enrol ) Are HCVpositive ( detectable HCV RNA ) ( Note : Subjects least 24 week completion treatment antiviral regimen remain free HCV determine HCV RNA test may enrol . ) Have cardiogenic shock hemodynamic instability within 24 hour prior surgery , require inotropes vasopressor mechanical device intraaortic balloon counterpulsation ( IABP ) Have require follow within week prior cardiac surgery : defibrillator permanent pacemaker , mechanical ventilation , IABP , leave ventricular assist device ( LVAD ) , form mechanical circulatory support ( MCS ) ( Note : The prophylactic insertion IABP preoperatively reason related exist LV pump function exclusionary ) . Have require cardiopulmonary resuscitation within 14 day prior cardiac surgery Have ongoing sepsis history sepsis within past 2 week untreated diagnosed infection prior Screening visit . Sepsis define presence confirm pathogen , along fever hypothermia , hypoperfusion hypotension Have total bilirubin alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; 2 time upper limit normal ( ULN ) time screen Have Child Pugh Class A liver disease ALT/AST upper limit normal Class B high . ( This criterion applicable patient population underlie chronic liver disease , i.e. , cirrhosis . )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>AKI</keyword>
</DOC>